Acromegaly
📧 Sign up to get email alerts when something new happens for Acromegaly.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-03-01FDA Approved: SOMAVERT — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for Somavert (pegvisomant) submitted by Pharmacia & Upjohn Company LLC. This action modifies the…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Peripheral Metabolic Effects of Somatostatin [NA]
The study reports the completed results of a trial assessing the peripheral metabolic effects of somatostatin in patients with acromegaly, g…
-
FDA approval · 2012-09-12FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for octreotide acetate (ANDA) by Hikma Pharmaceuticals USA Inc. The approval updates the labeling or…
-
FDA approval · 2012-08-13FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for bromocriptine mesylate (ANDA 078899) submitted by Zydus Pharmaceuticals USA Inc., granting regul…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Cardiac and Skeletal Muscle Energy Metabolism in Abnormal Growth Hormone States
This completed clinical trial studied cardiac and skeletal muscle energy metabolism in people with abnormal growth hormone states, including…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-07-03FDA Approved: SOMAVERT — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for SOMAVERT (pegvisomant) submitted by Pharmacia & Upjohn Company LLC.
-
FDA approval · 2012-06-28FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals, Inc.)
The FDA approved a supplemental application for octreotide acetate from Meitheal Pharmaceuticals, authorizing a generic version of the drug.…
-
CLINICAL_TRIALS research · 2012-06-06Clinical Trial Update: Prospective Study on Changes in Acromegaly
This is a prospective study update examining changes in acromegaly, sponsored by Radboud University Medical Center.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency [NA]
Clinical trial assessing the effects of growth hormone administration on cardiovascular risk in individuals cured of acromegaly with growth …
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Safety and Efficacy of Octreotide Long Acting Release (LAR) in Treatment Naïve Acromegalic Patients [Phase 3]
A Phase 3 trial evaluated the safety and efficacy of octreotide long-acting release (LAR) in treatment-naïve acromegaly patients and the stu…
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas [Phase 4]
A Phase 4 study evaluating octreotide acetate for acromegaly with micro or macroadenomas was terminated.
-
CLINICAL_TRIALS trial_result · 2012-04-11Clinical Trial Update: Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly [Phase 3]
A Phase 3 clinical trial completed evaluating the safety and efficacy of long-acting repeatable octreotide acetate injectable suspension ver…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients [NA]
Completed clinical trial evaluating co-treatment with pegvisomant and a somatostatin analogue in acromegaly patients with insulin resistance…
-
CLINICAL_TRIALS research · 2011-12-07Clinical Trial Update: Physiopathology of Sodium Retention in Acromegaly [NA]
This completed clinical trial, sponsored by Assistance Publique - Hôpitaux de Paris, studied the physiopathology of sodium retention in acro…
-
FDA label_change · 2011-09-30FDA Approved: SANDOSTATIN LAR DEPOT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA supplemental application for Sandostatin LAR Depot (octreotide acetate) submitted by Novartis Pharmaceuticals Corporation, involving cha…
-
CLINICAL_TRIALS trial_result · 2011-07-14Clinical Trial Update: Open Label Study of Octreotide Implant in Patients With Acromegaly [Phase 2]
An open-label Phase 2 clinical trial evaluated an octreotide implant for acromegaly. The study has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly [Phase 3]
Phase 3 trial evaluating the efficacy and safety of octreotide acetate in patients with uncontrolled acromegaly has completed and results ha…
-
FDA approval · 2011-03-04FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)
FDA approved a supplemental application for Somatuline Depot (lanreotide acetate) submitted by Ipsen Biopharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients [Phase 4]
Phase 4 trial evaluating high-dose Sandostatin LAR alone or in combination with a growth hormone receptor antagonist or a dopamine agonist i…
-
FDA approval · 2011-02-10FDA Approved: OCTREOTIDE ACETATE — Original Application (Mylan Institutional LLC)
The FDA approved the original ANDA for octreotide acetate from Mylan Institutional LLC. This marks the generic approval for this product.
-
CLINICAL_TRIALS research · 2010-12-22Clinical Trial Update: Sleep Apnea Syndrome on Acromegaly: Impact of the Treatment on the Carbohydrates Metabolism. [NA]
This clinical trial update investigates whether treatment of sleep apnea in patients with acromegaly affects carbohydrate metabolism, includ…
-
CLINICAL_TRIALS trial_result · 2010-12-20Clinical Trial Update: Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel [Phase 3]
Phase 3 trial assessing the ability of subjects with acromegaly or their partners to administer Somatuline Autogel.
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant [Phase 4]
This Phase 4 trial update investigates changes in left ventricular mass and cardiac function in patients with active acromegaly who are trea…
-
FDA approval · 2010-07-20FDA Approved: SOMAVERT — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for Somavert (pegvisomant) from Pharmacia & Upjohn Company LLC to update/expand its labeling.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients [Phase 3]
Phase 3 trial evaluating safety and biological activity of C2L-OCT-01 PR in acromegaly was terminated.